Ajooni Biotech

{
  "main_header": {
    "sid": 1002898,
    "name": "Ajooni Biotech",
    "stock_name": "Ajooni Biotech",
    "full_name": "Ajooni Biotech Ltd",
    "name_url": "stocks-analysis/ajooni-biotech",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "4.30",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "4.30",
    "mcapval": "73.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "AJOONI",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE820Y01021",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": 360697,
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ajooni-biotech-1002898-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ajooni Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-3973239",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AjooniBiotechLt_mojoScore_3973239.png",
        "date": "2026-05-04 10:10:17",
        "description": "Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Ajooni Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-3955900",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AjooniBiotechLt_mojoScore_3955900.png",
        "date": "2026-04-21 10:10:03",
        "description": "Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. While the rating was revised at the start of the year, the analysis below reflects the stock's current fundamentals, returns, and financial metrics as of 21 April 2026, providing investors with an up-to-date perspective on the company’s position in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Ajooni Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-3941569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AjooniBiotechLt_mojoScore_3941569.png",
        "date": "2026-04-10 10:10:03",
        "description": "Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, a rating that was last updated on 01 Jan 2026. While this rating change occurred earlier this year, the analysis and financial metrics discussed here reflect the company’s current position as of 10 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Ajooni Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-3923737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjooniBiotechLt_mojoScore_3923737.png",
        "date": "2026-03-30 10:10:31",
        "description": "Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Ajooni Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-3893338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjooniBiotechLt_mojoScore_3893338.png",
        "date": "2026-03-16 10:10:02",
        "description": "Ajooni Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. While the rating change occurred at the start of the year, the analysis and financial metrics discussed here reflect the company’s current position as of 16 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Ajooni Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-3868884",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjooniBiotechLt_mojoScore_3868884.png",
        "date": "2026-03-04 10:10:55",
        "description": "Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company's standing in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Ajooni Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-3849381",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AjooniBiotechLt_mojoScore_3849381.png",
        "date": "2026-02-21 10:10:05",
        "description": "Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Ajooni Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajooni-biotech-ltd-is-rated-sell-3830563",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AjooniBiotechLt_mojoScore_3830563.png",
        "date": "2026-02-10 10:10:07",
        "description": "Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      }
    ],
    "total": 112,
    "sid": "1002898",
    "stock_news_url": "https://www.marketsmojo.com/news/ajooni-biotech-1002898"
  },
  "announcements": [
    {
      "details": "Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Ajooni Biotech Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": "Ajooni Biotech Limited with respect to announcement dated 14-Oct-2019, that the Board of Directors in their meeting held on October 14, 2019 has considered and approved the resignation of Ms. Kanika Sapra, Company Secretary and Compliance Officer of the Company. On basis of above the Company is required to clarify following: 1. Date of resignation of Ms. Kanika Sapra. The response of the Company is awaited.",
      "source": "NSE",
      "caption": "Ajooni Biotech Limited - Clarification",
      "datetime": "23-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ajooni Biotech Ltd has announced <strong>2:10</strong> stock split, ex-date: 07 Oct 22",
          "dt": "2022-10-07",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Ajooni Biotech Ltd has announced <strong>1:9</strong> bonus issue, ex-date: 10 Mar 21",
          "dt": "2021-03-10",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Ajooni Biotech Ltd has announced <strong>1:1</strong> rights issue, ex-date: 07 May 24",
          "dt": "2024-05-07",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Ajooni Biotech Ltd is Rated Sell

2026-05-04 10:10:17

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Ajooni Biotech Ltd is Rated Sell

2026-04-21 10:10:03

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. While the rating was revised at the start of the year, the analysis below reflects the stock's current fundamentals, returns, and financial metrics as of 21 April 2026, providing investors with an up-to-date perspective on the company’s position in the Pharmaceuticals & Biotechnology sector.

Read full news article

Ajooni Biotech Ltd is Rated Sell

2026-04-10 10:10:03

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, a rating that was last updated on 01 Jan 2026. While this rating change occurred earlier this year, the analysis and financial metrics discussed here reflect the company’s current position as of 10 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Ajooni Biotech Ltd is Rated Sell

2026-03-30 10:10:31

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Ajooni Biotech Ltd is Rated Sell

2026-03-16 10:10:02

Ajooni Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. While the rating change occurred at the start of the year, the analysis and financial metrics discussed here reflect the company’s current position as of 16 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Ajooni Biotech Ltd is Rated Sell

2026-03-04 10:10:55

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company's standing in the Pharmaceuticals & Biotechnology sector.

Read full news article

Ajooni Biotech Ltd is Rated Sell

2026-02-21 10:10:05

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Ajooni Biotech Ltd is Rated Sell

2026-02-10 10:10:07

Ajooni Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

View All News